ImmuCell Announces Q4 2025 Sales Results: $7.6mln, 1.6% Decline YoY; Domestic Sales Up 8.7%

ImmuCell's Q4 2025 sales were $7.6 million, a 1.6% decline YoY. Domestic sales increased 8.7% to $7 million, while international sales dropped 52.6% to $0.6 million. Tri-Shield sales surged 41.3% to $6 million, while Dual-Force and other sales declined 53% to $1.7 million. Full-year 2025 sales rose 4.3% to $27.6 million, with domestic sales up 6.5% to $24.4 million and international sales down 9.6% to $3.3 million.